Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

E. Jabbour, H. Kantarjian, D. Jones, M. Talpaz, N. Bekele, S. O'Brien, X. Zhou, R. Luthra, G. Garcia-Manero, F. Giles, M. B. Rios, S. Verstovsek, J. Cortes

Research output: Contribution to journalArticlepeer-review

327 Scopus citations

Fingerprint

Dive into the research topics of 'Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate'. Together they form a unique fingerprint.

Medicine & Life Sciences